What is Evers Pharmacy?
Evers Pharmacy, based in Cambria Heights, NY, operates as a comprehensive, full-service independent pharmacy. The firm distinguishes itself through a high-touch service model that encompasses prescription fulfillment, specialized compounding, and essential immunization services. Beyond traditional dispensing, the company integrates medication therapy management and home delivery, positioning itself as a critical node in the local health and wellness ecosystem.
The company's market position is defined by its dedication to personalized patient care and health education. By focusing on the specific needs of the Cambria Heights community, Evers Pharmacy has cultivated a reputation for professional integrity and operational excellence. This focus on patient outcomes and localized support serves as a primary differentiator against larger, national retail pharmacy chains, allowing the firm to maintain strong customer loyalty and consistent service demand.
How much funding has Evers Pharmacy raised?
Evers Pharmacy has raised a total of $118K across 1 funding round:
Debt
$118K
Debt (2021): $118K with participation from PPP
Key Investors in Evers Pharmacy
PPP
Public-Private Partnership
What's next for Evers Pharmacy?
With the recent capital deployment, Evers Pharmacy is expected to prioritize the optimization of its operational workflows and the expansion of its clinical service offerings. The strategic focus will likely shift toward enhancing medication therapy management programs and potentially scaling its home delivery infrastructure to reach a broader demographic within the region.
As the pharmacy navigates the complexities of the healthcare sector, this late-stage funding provides the necessary liquidity to invest in advanced pharmacy management technologies and staff development. By maintaining its core mission of community health while adopting more efficient operational practices, Evers Pharmacy is poised to strengthen its competitive advantage and ensure long-term viability in the independent pharmacy sector.
